---
$id: https://graph.org.ai/products/commodity/51271603
$type: Product
source: UNSPSC
code: "51271603"
title: "Bupivacaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bupivacaine

**UNSPSC Code**: 51271603
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C18H28N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y8335394RO, chemically known as 2-piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)- but generally known as bupivacaine, which bears US NIH Compound Identifier 2474. Bupivacaine most often comes in base and hydrochloride forms. European Medicines Agency schedules Bupivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05983MIG. The term BUPIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules bupivacaine in its Anatomical Therapeutic Chemical (ATC) Classification. BUPIVACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bupivacaine under HS 29333999 and SITC 51574. As of Q4 2014, BUPIVACAINE remains the US FDA Preferred Term for this commodity. Bupivacaine bears US NLM identifiers UMLS ID C0006400 and NCI Concept Code C62011. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)CCCC.

